HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Janz Selected Research

Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)

12/2005Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Janz Research Topics

Disease

8Hodgkin Disease (Hodgkin's Disease)
10/2014 - 08/2003
5Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2021 - 12/2005
5Neoplasms (Cancer)
07/2013 - 01/2002
4B-Cell Lymphoma (Lymphoma, B Cell)
04/2022 - 04/2004
4Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 10/2020
3Lymphoma (Lymphomas)
01/2022 - 05/2006
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2022
2Multiple Myeloma
10/2009 - 05/2003
1Infections
04/2021
1Lung Diseases (Lung Disease)
04/2021
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2021
1Carcinogenesis
12/2017
1Peripheral Nervous System Diseases (PNS Diseases)
12/2017
1Hematologic Neoplasms (Hematological Malignancy)
10/2014
1Primary Effusion Lymphoma
05/2007
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2005
1Autoimmune Diseases (Autoimmune Disease)
01/2004
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2004
1Acute Promyelocytic Leukemia
08/2003
1Breast Neoplasms (Breast Cancer)
01/2002

Drug/Important Bio-Agent (IBA)

5Transcription Factors (Transcription Factor)IBA
12/2017 - 12/2005
3BI 836826IBA
02/2021 - 10/2020
3Proteins (Proteins, Gene)FDA Link
02/2006 - 01/2002
2Anaplastic Lymphoma KinaseIBA
10/2021 - 01/2021
2Pyridinolcarbamate (P23)IBA
10/2021 - 04/2009
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
07/2013 - 01/2004
2NF-kappa B (NF-kB)IBA
12/2005 - 08/2003
1Histone DemethylasesIBA
04/2022
1Histones (Histone)IBA
04/2022
1Bortezomib (Velcade)FDA Link
01/2022
1ibrutinibIBA
01/2022
1tisagenlecleucelIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1GlucocorticoidsIBA
04/2021
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2018
1ChromatinIBA
10/2014
1Interferon Regulatory FactorsIBA
10/2014
1TensinsIBA
07/2013
1Sorafenib (BAY 43-9006)FDA Link
11/2011
1Macrophage Colony-Stimulating FactorIBA
05/2010
1Co-Repressor ProteinsIBA
05/2010
1CCAAT-Enhancer-Binding Protein-betaIBA
10/2009
1CytokinesIBA
10/2008
1interleukin-21 (interleukin 21)IBA
10/2008
1Basic Helix-Loop-Helix Transcription FactorsIBA
05/2007
1PAX5 Transcription FactorIBA
05/2006
1Activating Transcription Factor 3IBA
03/2006
1pomalidomideIBA
05/2005
1Thalidomide (Thalomid)FDA Link
05/2005
1Death Domain ReceptorsIBA
04/2004
1AntibodiesIBA
01/2004
1AutoantigensIBA
01/2004
1Immunoglobulin M (IgM)IBA
01/2004
1anti-IgMIBA
01/2004
1Pharmaceutical PreparationsIBA
08/2003
1Arsenic Trioxide (Trisenox)FDA Link
08/2003
1ArsenicIBA
08/2003
1Chemokine CCL3IBA
05/2003
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2002
1Plasminogen Activator Inhibitor 1IBA
01/2002
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2002
1Plasminogen InactivatorsIBA
01/2002
1Biological FactorsIBA
01/2002

Therapy/Procedure

1Therapeutics
01/2022
1Breast Implants (Breast Implant)
01/2021
1Drug Therapy (Chemotherapy)
01/2002